You are viewing: China ECMO Machines Market analysis
Part of: ECMO Machines Market (Global)

The China ECMO Machines Market was valued at $27.05 Million in 2025 and projected to reach to $39.64 Million by 2030, representing a compound annual growth rate of 7.9%. China's ECMO machines market is positioned for sustained growth as the country prioritizes critical care infrastructure development and cardiac intervention capabilities.

China ECMO Machines Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China ECMO Machines Market Trends and Insights

  • This 7.9% compound annual growth rate reflects China's increasing investment in critical care infrastructure and advanced cardiac support technologies.
  • China's healthcare system modernization, coupled with rising prevalence of cardiovascular and respiratory diseases, is driving demand for extracorporeal membrane oxygenation devices across major urban centers and tertiary care hospitals. The expansion of China's ECMO market is supported by government healthcare initiatives, growing patient awareness, and the establishment of specialized cardiac and pulmonary centers.
  • China's aging population and higher incidence of acute respiratory distress syndrome have accelerated adoption of ECMO technology in intensive care units.
  • Between 2025 and 2030, China is expected to see increased penetration of ECMO machines in both public and private healthcare facilities, driven by technological improvements and competitive pricing strategies tailored to the Chinese market..

Key Market Statistics

  • CAGR (2025-2030) 7.9% CAGR
  • Market Size, 2025 ~USD 27.05 Million
  • Forecast, 2030 ~USD 39.64 Million
  • Country China

China ECMO Machines Market Overview

Rapid Market Expansion :

China's ECMO machines market is growing at 7.9% CAGR, significantly outpacing the global rate of 5.8%, driven by healthcare modernization and increased critical care demand.

Healthcare Infrastructure Investment :

China's government-backed initiatives to upgrade hospital critical care units and cardiac centers are accelerating ECMO adoption across tier-1 and tier-2 cities.

Rising Cardiovascular Disease Burden :

Increasing prevalence of cardiovascular and respiratory conditions in China's aging population is creating sustained demand for advanced life support technologies like ECMO.

Market Valuation Growth :

The market is projected to grow from USD 27.05 million in 2025 to USD 39.64 million by 2030, representing a 46.5% increase over the five-year forecast period.

China ECMO Machines Market Dynamics

  • Government healthcare reforms, coupled with rising disposable incomes and increased awareness of advanced treatment options, are driving hospital investments in ECMO technology.
  • Major medical centers in Beijing, Shanghai, and Guangzhou are leading adoption, with expansion expected in secondary cities. The market will benefit from technological localization efforts, competitive pricing strategies by manufacturers, and integration of ECMO into standardized critical care protocols.
  • Regulatory support for advanced medical devices and training programs for healthcare professionals will further accelerate market penetration.
  • By 2030, ECMO machines are expected to become standard equipment in major tertiary care hospitals across China..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • China's ECMO machines market is valued at USD 27.05 million in 2025 and is forecast to reach USD 39.64 million by 2030, representing a 7.9% CAGR.
    • China's aging population and rising cardiovascular disease burden are primary drivers of ECMO adoption in critical care settings.
    • Government healthcare reforms and increased ICU capacity expansion across China are accelerating market growth through 2030.
    • China's competitive pricing environment and domestic manufacturing capabilities are positioning the country as a key growth market in the Asia Pacific region.

    ECMO Machines Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.8% from 2025 to 2030
    Largest Segment ADULT PATIENTS (Patient Type)
    Market Size Base Year (Billions) ~USD 0.65 (2025)
    Revenue Forecast (Billions) ~USD 0.86 (2030)
    Segments Covered Product, Type, Modality, Patient Type, Application, End User

    China ECMO Machines Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Components
    • Machines

    By Type

    • Accessories
    • Cannulas
    • Controllers
    • Oxygenators
    • Pumps

    By Modality

    • Arteriovenous Ecmo
    • Venoarterial Ecmo
    • Venovenous Ecmo

    By Patient Type

    • Adult Patients
    • Neonates
    • Pediatric Patients

    By Application

    • Cardiac Applications
    • Extracorporeal Cardiopulmonary Resuscitation (Ecpr)
    • Respiratory Applications

    By End User

    • Academic & Research Institutions
    • Hospitals
    • Specialty Clinics

    CHINA: ECMO MACHINES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ACADEMIC & RESEARCH INSTITUTIONS6.967.377.838.328.869.4610.1110.836.7
    HOSPITALS25.3627.1329.0831.233.5636.1639.0442.227.7
    SPECIALTY CLINICS4.354.574.85.065.345.645.986.345.7
    TOTAL36.6739.0741.7144.5747.7551.2655.1359.47.3

    Target Audience

    • Medical Device Manufacturers : Manufacturers need China-specific market data to assess market entry viability, competitive positioning, and revenue potential in this rapidly expanding critical care segment.
    • Healthcare Investors & PE Firms : Investors require detailed market intelligence on China's ECMO sector to evaluate investment opportunities, growth trajectories, and portfolio company expansion strategies.
    • Hospital & Healthcare Administrators : Hospital decision-makers need market insights to justify ECMO equipment procurement, budget allocation, and critical care service expansion planning.
    • Market Research & Consulting Firms : Research professionals require granular China market data to support client advisory services, competitive analysis, and strategic planning engagements.
    • Government & Policy Organizations : Healthcare policymakers and regulatory bodies need market intelligence to inform critical care infrastructure planning and medical device procurement policies.

    Key Companies in the China ECMO Machines Market

    CompanyHQOwnershipStrongest segments
    GETINGESwedenPublic CompanyAcute Care Therapies,Surgical Workflows,Life Science,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyDialysis services (outpatient and in-hospital ESRD/acute),Dialysis machines, cyclers, and water treatment systems,Dialysis consumables and solutions,
    LIVANOVA PLCUnited KingdomPublic CompanyCardiopulmonary (heart-lung machines, oxygenators, autotransfusion, perfusion tubing, cannula, services),Neuromodulation (VNS Therapy for epilepsy and depression, aura6000 development),
    NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products, functional products,Pharmaceutical-Related (CDMO for injectables and oral drugs, kit products),
    WEIGAO GROUP CO., LTD.ChinaPublic CompanyMedical Device Products (infusion, clinical nursing, perioperative, urinary, rehab, extracorporeal circulation),Orthopedic Products (spine, joint, trauma, sports medicine, bone repair, spinal endoscope),Pharma Packaging Products (prefilled systems, packaging consumables, automatic drug delivery),
    ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
    MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices,Orthopedics Devices,Cardiac Rhythm Management,

    GETINGE

    Getinge is a Swedish public company founded in 1904 that employs 11,754 people and operates in the medical technology sector.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees specializing in medical devices and healthcare solutions.

    TERUMO CORPORATION

    Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, operating in the medical device and healthcare industry.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, providing dialysis and renal care services globally.

    LIVANOVA PLC

    LivaNova PLC is a United Kingdom-based public company founded in 2015 with 3,300 employees, focused on neuromodulation and cardiac surgery solutions.

    NIPRO

    Nipro is a Japanese public company established in 1947 with 38,593 employees, manufacturing medical devices and pharmaceutical products.

    WEIGAO GROUP CO., LTD.

    Weigao Group Co., Ltd. is a Chinese public company founded in 1988 with 13,307 employees, specializing in medical device manufacturing.

    ABBOTT

    Abbott is a United States-based public company founded in 1888 with 115,000 employees, operating across diagnostics, medical devices, nutrition, and pharmaceuticals.

    MICROPORT SCIENTIFIC CORPORATION

    MicroPort Scientific Corporation is a Chinese public company established in 1998 with 6,547 employees, developing and manufacturing medical devices.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise valuation metrics for China's ECMO market with 7.9% CAGR, enabling accurate financial forecasting and investment planning specific to this high-growth region.
    • Competitive Landscape Intelligence : Understand market dynamics, key players, and competitive positioning within China's ECMO sector to identify partnership and expansion opportunities.
    • Regional Demand Drivers : Gain insights into China-specific factors driving ECMO adoption, including healthcare policy changes, aging demographics, and disease prevalence patterns.
    • Strategic Market Entry : Develop informed go-to-market strategies for China with detailed analysis of hospital infrastructure, regulatory requirements, and regional purchasing behaviors.
    • Investment Decision Support : Make confident capital allocation decisions with comprehensive market forecasts, growth projections, and risk assessments tailored to China's healthcare sector.

    Frequently asked questions

    What is the current size of China's ECMO machines market?

    China's ECMO machines market was valued at USD 27.05 million in 2025 and is expected to grow to USD 39.64 million by 2030.

    What is the projected growth rate for ECMO machines in China?

    China's ECMO machines market is projected to grow at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2030.

    What factors are driving ECMO machine demand in China?

    Key drivers include China's aging population, rising prevalence of cardiovascular and respiratory diseases, government healthcare modernization initiatives, and expansion of critical care infrastructure.

    Which healthcare facilities in China are adopting ECMO technology?

    ECMO machines are being adopted across China's tertiary care hospitals, specialized cardiac and pulmonary centers, and intensive care units in both public and private healthcare facilities.

    How does China's ECMO market compare to other Asia Pacific countries?

    China's 7.9% CAGR positions it as a high-growth market within Asia Pacific, driven by its large patient population, healthcare investment, and domestic manufacturing capabilities.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size of the ECMO machines market. Exhaustive secondary research was done to collect information on the ECMO market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ECMO market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ECMO market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the ECMO market. Primary sources from the demand side included hospitals, academic & research institutions, specialty clinics, researchers, lab technicians, purchase managers, and stakeholders in corporate & government bodies.

    The following is a breakdown of the primary respondents:

    ECMO Machines Market

    Note 1: C-level primaries include CEOs, COOs, and CTOs.

    Note 2: Others include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ECMO market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    ECMO Machines Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ECMO machines and components. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    An ECMO machine acts as an artificial heart and lung for a patient whose heart or lungs cannot provide enough blood flow or oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of ECMO is to let the heart and lungs recover while the patient is supported by the ECMO machine.

    Stakeholders

    • Manufacturers of ECMO Machine Products and Related Devices
    • Suppliers and Distributors of ECMO Machine Devices
    • Hospitals, Clinics, and Medical Colleges
    • Medical Device Procurement Agencies
    • Government Bodies/Municipal Corporations
    • Business Research and Consulting Service Providers
    • Venture Capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the oxygen concentrators market based on product, modality, patient type, application, end user, and region  
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall oxygen concentrators market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the oxygen concentrators market in six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa, and GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full ECMO Machines Market Report

    Full forecast, segment splits, and company analysis for all ECMO Machines Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status